Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

The high molecular heterogeneity of bladder tumours is responsible for significant variations in disease course, as well as elevated recurrence and progression rates, thereby hampering the introduction of more effective targeted therapeutics. The implementation of precision oncology settings support...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Azevedo, Rita, Peixoto, Andreia, Gaiteiro, Cristiana, Fernandes, Elisabete, Neves, Manuel, Lima, Luís, Santos, Lúcio Lara, Ferreira, José Alexandre
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2017
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710962/
https://ncbi.nlm.nih.gov/pubmed/29207682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19433
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg